March 2, 2013 (Washington, D.C.) – The Food and Drug Administration (FDA) has recently issued alerts or other safety information about a number of products, including metal-on-metal hip implants, which release metal particles into the bloodstream, sleep drugs that reduce morning alertness—especially in women, and a motion sickness drug packaged in error as an iron supplem
Error message
Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.
Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.
March 2, 2013 (Washington, D.C.) – The Food and Drug Administration (FDA) has recently issued alerts or other safety information about a number of products, including metal-on-metal hip implants, which release metal particles into the bloodstream, sleep drugs that reduce morning alertness—especially in women, and a motion sickness drug packaged in error as an iron supplem
Recent comments